Risky Business or Strategic Advantage? GenAI Chatbots in Rx Promotions
The “Risky Business or Strategic Advantage? GenAI Chatbots in Rx Drug Promotion” webinar will help pharma marketing and regulatory teams understand how to use GenAI chatbots compliantly and avoid the traps of real-time publishing. You’ll learn:
- Use cases for GenAI chatbots in pharma promotions
- Assessing risk—what to consider
- Strategies for mitigating potential damage ranging from brand credibility to adverse outcomes
- Handling “submission prior to first use” requirements
- Creating low-risk and regulatory-compliant GenAI content
Plus, Jason has set aside 30 minutes to answer audience questions. Register now to save your seat!
ABOUT SPEAKER JASON COBER
Former FDA/OPDP Lead Project Manager
Jason Cober is the former Lead Project Manager in the FDA’s Office of Prescription Drug Promotion (OPDP). Jason joined the FDA in 2008 and served in this role from 2016 until 2025, working closely with industry on digital, modular, and GenAI content submissions. He has over 15 years’ experience with the Agency’s electronic Common Technical Document (eCTD) specification and guidance development. At OPDP, Jason led the office’s eCTD outreach efforts, supporting industry compliance and regulatory clarity for promotional submissions.
About the Insider Insights Webinar Series
Hale Advisors developed the Insider Insights webinar series to fill the gap in OPDP information and access created by the April 2025 reduction in force (RIF). The series focuses on essential pharmaceutical advertising and promotion compliance topics, with each session delivering critical information and insight along with a 30-minute forum for audience questions.
